About NanoViricides, Inc.

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.13$ per share.

The book value per share is 0.28$

NanoViricides, Inc. website

Create a solid portfolio with NNVC

Add NNVC to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -9M - -8M -0.13 - - 66M 0.28 -7M - -7M